menu
    • menu

    Company profile for TLC Therapeutics

    NEW Drugs in Dev: 3
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    TLC therapeutics is a privately-held specialty pharmaceutical company focused on identifying and commercializing innovative pharmaceutical products with unique dosage forms that address unmet needs. TLC590 is a non-opioid, BioSeizer® sustained release formulation of ropivacaine designed to prolong the retention time of ropivacaine around the injection site as a drug depot, simultaneously extending its therapeutic period and ...
    TLC therapeutics is a privately-held specialty pharmaceutical company focused on identifying and commercializing innovative pharmaceutical products with unique dosage forms that address unmet needs. TLC590 is a non-opioid, BioSeizer® sustained release formulation of ropivacaine designed to prolong the retention time of ropivacaine around the injection site as a drug depot, simultaneously extending its therapeutic period and reducing unwanted systemic exposure.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    TLC TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1498-M Reisterstown Road, Suite 313, Pikesville, MD 21208
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.makingmedicinesbetter.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/tlc-therapeutics-llc/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    TLC Announces Details of Stock Swap Transactions
    TLC Announces Details of Stock Swap Transactions

    05 Jul 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/07/05/2257560/0/en/TLC-Announces-Details-of-Stock-Swap-Transactions.html

    GLOBENEWSWIRE
    05 Jul 2021
    Share Share
    TLC Reports Fiscal Year End 2020 Financial Results and Provides Business Update
    TLC Reports Fiscal Year End 2020 Financial Results and Provides Business Update

    05 Feb 2021

    // BIOSPACE

    https://www.biospace.com/article/releases/tlc-reports-fiscal-year-end-2020-financial-results-and-provides-business-update/

    BIOSPACE
    05 Feb 2021
    Share Share
    TLC Receives Australian and Taiwan Approval to Initiate Phase I Clinical Trial
    TLC Receives Australian and Taiwan Approval to Initiate Phase I Clinical Trial

    07 Oct 2020

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2020/10/07/2104662/0/en/TLC-Receives-Australian-and-Taiwan-Approval-to-Initiate-Phase-I-Clinical-Trial-of-TLC19-Inhalable-Liposomal-Hydroxychloroquine-for-COVID-19.html

    GLOBENEWSWIRE
    07 Oct 2020
    Share Share
    TLC to Present at Oppenheimer Fall Healthcare Life Sciences & Med Tech Summit
    TLC to Present at Oppenheimer Fall Healthcare Life Sciences & Med Tech Summit

    21 Sep 2020

    // BIOSPACE

    https://www.biospace.com/article/releases/tlc-to-present-at-oppenheimer-fall-healthcare-life-sciences-and-med-tech-summit/?s=73

    BIOSPACE
    21 Sep 2020
    Share Share
    TLC Announces Topline Results for TLC590 Phase II Trial for Postsurgical Pain
    TLC Announces Topline Results for TLC590 Phase II Trial for Postsurgical Pain

    30 May 2020

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2020/05/31/2041231/0/en/TLC-Announces-Topline-Results-for-TLC590-Phase-II-Trial-for-Postsurgical-Pain-Management-following-Bunionectomy.html

    GLOBENEWSWIRE
    30 May 2020
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search